Form ARS 4D Molecular Therapeutic For: Dec 31
Tweet
Share
E-mailATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- H.C. Wainwright Reiterates Buy Rating on 4D Molecular Therapeutics (FDMT)
- Ocean Power Technologies to Announce Fourth Quarter and Fiscal Results on July 23, 2026
- SphingoTec CEO to Attend ADLM 2026
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
